🔎 Trials Near Me

Home › Type 2 Diabetes › Pennsylvania

Pag-aaral pangklinika para sa Type 2 Diabetes sa Pennsylvania

30 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Suburban Research Associates, West Chester
  • Cardiology Consultants of Philadelphia Yardley, Yardley
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07783802

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • Heritage Valley Medical Group, Beaver
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07564414

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Heritage Valley Medical Group, Beaver
  • Capital Area Research, LLC, Camp Hill
  • Thomas Jefferson University, Philadelphia
  • at 8 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Heritage Valley Medical Group, Beaver
  • Preferred Primary Care Physicians-Pittsburgh-63932, Pittsburgh
  • Preferred Primary Care Physicians, Pittsburgh
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Capital Area Research, Camp Hill
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 55 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06112418

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
  • Preferred Primary Care Physicians, Uniontown
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Scottdale
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

Phenotyping Genetic Risk for Type 2 Diabetes

  • Childrens Hospital of Philadelphia, Philadelphia
  • University of Pennsylvania, Philadelphia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 10 hanggang 70 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT04024631

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Philadelphia
  • AURORA-2 Clinical Site, Pittsburgh
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • VA Pittsburgh Healthcare System, Pittsburgh
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Frontier Clinical Research, LLC, Scottdale
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06897475

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Northeast Clinical Research Center, Bethlehem
  • Suburban Research Associates, West Chester
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • Preferred Primary Care Physicians, Inc., Uniontown
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Feasterville-Trevose
  • Research Site, Philadelphia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Suburban Research Associates, West Chester
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Children's Hosptl Philadelphia, Philadelphia
Nagre-recruitPhase 3
Edad 10 hanggang 18 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07282613

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Children's Hospital of Philadelphia, Philadelphia
  • St Christophers Hospital For Children, Philadelphia
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06739122

The GRoceries Aimed at Increasing Nutrition Study

  • University of Pennsylvania, Philadelphia
Nagre-recruitMay bayad para sa mga kalahok
Edad 45 hanggang 70 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07167004

Pharmacogenetics of Response to GLP1R Agonists

  • Amish Research Clinic, Lancaster
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05071898

CGM for Management of Type 2 Diabetes in Pregnancy

  • University of Pennsylvania, Philadelphia
Nagre-recruit
Edad 18 hanggang 50 · Kababaihan · Na-update Hun 29, 2026 · NCT06628453

Sleep and Glycemic Control in Type 2 Diabetes Adolescents

  • Children's Hospital of Philadelphia, Philadelphia
Nagre-recruit
Edad 12 hanggang 20 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT04213547

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

  • Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
Edad 8 hanggang 15 · Lahat ng kasarian · Na-update May 7, 2026 · NCT06525259

Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 13 pataas · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT07216118

Transformative Research in Diabetic Nephropathy 2.0

  • Penn Presbyterian Medical Center, Philadelphia
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT07444203

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

  • Children's Hospital of Pittsburgh, Pittsburgh
Nagre-recruit
Edad 16 hanggang 24 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT07270016

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT05277558

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

  • Thomas Jefferson University, Philadelphia
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Okt 14, 2025 · NCT07184775

Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes

  • Reading Hospital, an affiliate of Tower Health, West Reading
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2025 · NCT05893927

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.